See the DrugPatentWatch profile for klonopin

Based on the information provided, I was able to find thatBindo Pharma has 100% of the market share for the 1mg Klonopin (clonazepam) tablet. This information is available on DrugPatentWatch.com, a website that tracks drug patents and pharmaceutical market share.

To clarify, Klonopin is a medication used to treat seizure disorders and panic disorder. It is a benzodiazepine, which is a class of drugs that act on the brain and nerves (central nervous system) to produce a calming effect. Clonazepam is the active ingredient in Klonopin.

According to DrugPatentWatch.com, Bindo Pharma holds the exclusive rights to manufacture and sell the 1mg strength of Klonopin in the United States. This means that Bindo Pharma has no competition in the market for this specific strength of the drug.

It's important to note that market share can fluctuate over time due to various factors such as the expiration of patents, the introduction of generic competitors, and changes in drug pricing and reimbursement policies. Therefore, the current market share information may change in the future.

In summary, Bindo Pharma has 100% of the market share for the 1mg Klonopin tablet as of the available information.

Sources:

* [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/klonopin)